Cargando…
Statistical challenges in the development and evaluation of marker-based clinical tests
Exciting new technologies for assessing markers in human specimens are now available to evaluate unprecedented types and numbers of variations in DNA, RNA, proteins, or biological structures such as chromosomes. These markers, whether viewed individually, or collectively as a 'signature',...
Autor principal: | McShane, Lisa M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379945/ https://www.ncbi.nlm.nih.gov/pubmed/22642713 http://dx.doi.org/10.1186/1741-7015-10-52 |
Ejemplares similares
-
A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker Codevelopment
por: Taube, Sheila E., et al.
Publicado: (2009) -
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An
Abridged Explanation and Elaboration
por: Sauerbrei, Willi, et al.
Publicado: (2018) -
Study design flaws and statistical challenges in evaluating fertility treatments
por: Wilkinson, Jack, et al.
Publicado: (2021) -
Editorial Commentary: Understanding BCG Is the Key to Improving It
por: McShane, Helen
Publicado: (2014) -
Improving Tuberculosis Vaccine Trial Efficiency: A Tough Nut to Crack
por: McShane, Helen
Publicado: (2023)